US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.916
  • -0.005-0.59%
Close Dec 20 16:00 ET
  • 0.958
  • +0.043+4.64%
Post 20:01 ET
156.31MMarket Cap-4.36P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Seres Therapeutics Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
25.83M
0
-25.83M
Miss Est.
+8233.33%
--
-100.00%
EPS
-0.08
0.58
+0.66
Beat Est.
+78.94%
+256.76%
+844.54%
Analyst Rating
Hold

Dec 21, 2024

Seres Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.500M--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 25.833M--
Aug 13, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 250.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.500M--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 25.833M--
Aug 13, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 250.000K--

Unlock Free Earnings Estimates

Seres Therapeutics Earnings Reports

  • Seres Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 23:33

  • Seres Therapeutics | 8-K: SERES THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

    Nov 13 21:07

  • Seres Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 22:42

  • Seres Therapeutics | 8-K: SERES THERAPEUTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

    Aug 13 19:07

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Hold

    • Buy

      50.00%

    • Hold

      0.00%

    • Sell

      50.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data